NLS Pharmaceutics AG
NLSP1.880USD
+0.080+4.44%
Close 08/04, 16:00（ET）Quotes delayed by 15 min
1.889USD+1.889After-hours (ET)
5.94MMarket Cap
--P/E TTM
NLS Pharmaceutics AG
1.880
+0.080+4.44%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2024H2
FY2024H1
FY2023H2
FY2023H1
FY2022H2
FY2022H1
FY2021H2
FY2021H1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-14.63%-2.74M
79.02%-1.53M
61.57%-2.39M
4.81%-7.30M
-19.44%-6.21M
21.25%-7.67M
---5.20M
---9.73M
Net income from continuing operations
101.21%55.02K
73.26%-2.04M
41.96%-4.56M
11.90%-7.61M
-6.97%-7.85M
-87.71%-8.64M
---7.34M
---4.60M
Operating gains losses
----
0.00%5.70K
0.00%5.70K
0.00%5.70K
13.44%5.70K
13.58%5.70K
--5.03K
--5.02K
Other non-cash items
-3484.47%-2.54M
364.69%40.85K
-92.24%74.96K
-39.00%-15.43K
2756.74%966.46K
-108.37%-11.10K
--33.83K
--132.68K
Change in working capital
-116.24%-322.52K
50.78%400.21K
207.47%1.99M
-72.94%265.42K
-69.25%646.02K
118.62%980.79K
--2.10M
---5.27M
-Change in receivables
----
----
--0.00
----
----
----
---12.04K
---9.76K
-Change in prepaid expenses
4.18%-322.32K
332.48%687.54K
-190.84%-336.39K
-190.22%-295.74K
-56.80%370.32K
131.33%327.79K
--857.29K
---1.05M
-Change in other current assets
--16.60K
----
----
----
----
----
----
----
-Change in other current liabilities
----
----
11.40%-42.24K
----
---47.68K
----
----
----
Cash from non-recurring investing activities
Cash from operating activities
-14.63%-2.74M
79.02%-1.53M
61.57%-2.39M
4.81%-7.30M
-19.44%-6.21M
21.25%-7.67M
---5.20M
---9.73M
Investing cash flow
Net cash from continuing investing activities
--3.92K
----
--0.00
----
----
----
--6.80K
--32.76K
Capital expenditures
--3.92K
----
--0.00
----
----
----
--6.80K
--32.76K
Net cash flow from disposal of fixed assets
--3.92K
----
--0.00
----
----
----
--6.80K
--32.76K
Cash from non-current investing activities
Net cash flow from investing activities
---3.92K
----
--0.00
----
----
----
---6.80K
---32.76K
Financing cash flow
Cash flow from continuous financing activities
135.90%3.85M
--1.19M
-88.17%1.63M
-100.00%0.00
289.13%13.81M
-78.63%3.59M
--3.55M
--16.79M
Net cash flow from debt Issuance/repayment
-88.08%194.72K
---194.72K
38.96%1.63M
100.00%0.00
--1.18M
83.38%-349.82K
--0.00
---2.10M
Net cash flow from common stock issuance/repurchase
--3.87M
--1.38M
-100.00%0.00
-100.00%0.00
105.03%7.28M
-82.34%1.94M
--3.55M
--11.00M
Proceeds from issuance of warrants
--173.12K
----
-100.00%0.00
-100.00%0.00
28196531.58%5.36M
-74.72%2.00M
--19.00
--7.89M
Net cash flow from other financing activities
---386.33K
----
----
----
----
----
--0.00
--0.00
Net cash from non-recurrent financing activities
Net cash from financing activities
135.90%3.85M
--1.19M
-88.17%1.63M
-100.00%0.00
289.13%13.81M
-78.63%3.59M
--3.55M
--16.79M
Net cash flow
Beginning cash balance
-66.53%552.76K
-89.97%897.68K
21.95%1.65M
64.76%8.95M
-80.91%1.35M
5695.69%5.43M
--7.09M
--93.71K
Current period cash flow changes
247.61%1.11M
95.27%-344.92K
-109.93%-753.77K
-78.98%-7.30M
557.23%7.59M
-158.26%-4.08M
---1.66M
--7.00M
Effect of exchange rate changes
----
100.00%0.00
201.71%416.00
-234.63%-416.00
---409.00
101.25%309.00
--0.00
---24.74K
Ending cash balance
85.52%1.67M
-66.53%552.76K
-89.97%897.68K
21.95%1.65M
64.76%8.95M
-80.91%1.35M
--5.43M
--7.09M
Free cash flow
-14.80%-2.74M
----
---2.39M
----
----
----
---5.21M
---9.77M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
